Pinnacle Family Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,806
Closed -$3.04M 127
2025
Q1
$3.04M Sell
23,806
-167
-0.7% -$22.6K 1.66% 16
2024
Q4
$3.17M Buy
23,973
+986
+4% +$139K 1.53% 17
2024
Q3
$3.35M Buy
+22,987
New +$3.33M 1.73% 17

Other funds holding IBB

Pinnacle Family Advisors's IBB Position: Q2 2025 in Review

Pinnacle Family Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 23,806 shares — an estimated $3.04M sold.

Pinnacle Family Advisors first reported a position in IBB in Q3 2024 and held it in 3 quarters. The position peaked at $3.35M in Q3 2024. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Pinnacle Family Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Pinnacle Family Advisors sold 23,806 iShares Biotechnology ETF shares in Q2 2025, an estimated $3.04M.
  • Pinnacle Family Advisors first reported a position in iShares Biotechnology ETF in Q3 2024 and held it in 3 quarters.
  • Pinnacle Family Advisors's iShares Biotechnology ETF position peaked at $3.35M in Q3 2024.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Pinnacle Family Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.